{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:18:15Z","timestamp":1762867095550},"reference-count":53,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T00:00:00Z","timestamp":1497398400000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/open-government-licence\/version\/3\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.vaccine.2017.03.066","type":"journal-article","created":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T01:30:21Z","timestamp":1491874221000},"page":"3598-3606","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM 197 , DT and TT glycoconjugate vaccines"],"prefix":"10.1016","volume":"35","author":[{"given":"Nicola J.","family":"Beresford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian M.","family":"Feavers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Corbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xilian","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bolgiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.03.066_b0005","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.vaccine.2008.01.022","article-title":"Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases","volume":"26","author":"Bardotti","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.066_b0010","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.vaccine.2004.10.021","article-title":"Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines against Neisseria meningitidisgroups Y and W135","volume":"23","author":"Bardotti","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.066_b0015","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1128\/IAI.70.7.3707-3713.2002","article-title":"Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses","volume":"70","author":"Berry","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.066_b0020","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1016\/j.vaccine.2012.08.021","article-title":"Relative stability of meningococcal serogroup A and X polysaccharides","volume":"30","author":"Berti","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.066_b0025","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0021-9258(19)41784-5","article-title":"Structural determination of the sialic acid polysaccharide antigens of Neisseria meningitidis serogroups B and C with carbon 13 nuclear magnetic resonance","volume":"250","author":"Bhattacharjee","year":"1975","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2017.03.066_b0030","unstructured":"Bolgiano B, Gao F, Beresford N, Haralson S, Hosken N, Hennessey J, et al. Pre-clinical stability evaluation of the meningococcal (A, C, Y, W, X) polysaccharide conjugate vaccine, MCV-5, confirms its integrity and immunogenicity. In: International Pathogenic Neisseria Conference (Poster Abstract); 2016."},{"key":"10.1016\/j.vaccine.2017.03.066_b0035","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1016\/S0264-410X(01)00024-X","article-title":"Effect of physico-chemical modification on the immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccines","volume":"19","author":"Bolgiano","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.066_b0040","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection\u2013serum bactericidal antibody activity","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.066_b0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/inthealth\/ihw037","article-title":"The importance of surveillance: group W meningococcal disease outbreak response and control in England","volume":"6","author":"Campbell","year":"2016","journal-title":"Int Health"},{"key":"10.1016\/j.vaccine.2017.03.066_b0050","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/JCM.30.1.154-159.1992","article-title":"Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay","volume":"30","author":"Carlone","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.066_b0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.biologicals.2013.03.003","article-title":"Serogroup quantitation of multivalent polysaccharide and polysaccharide-conjugate meningococcal vaccines from China","volume":"41","author":"Cook","year":"2013","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2017.03.066_b0060","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1432-1033.1997.00320.x","article-title":"Comparison of the diphtheria mutant toxin, CRM197, with a Haemophilus influenzae type-b polysaccharide-CRM197 conjugate by optical spectroscopy","volume":"246","author":"Crane","year":"1997","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2017.03.066_b0065","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1016\/S0021-9258(19)41257-X","article-title":"Capsular polymer of Haemophilus influenzae, type b. I. Structural characterization of the capsular polymer of strain Eagan","volume":"250","author":"Crisel","year":"1975","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2017.03.066_b0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40121-016-0107-0","article-title":"Meningococcal vaccinations","volume":"5","author":"Crum-Cianflone","year":"2016","journal-title":"Infect Diseases Therapy"},{"key":"10.1016\/j.vaccine.2017.03.066_b0075","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.4161\/hv.29696","article-title":"A physico-chemical assessment of the thermal stability of pneumococcal conjugate vaccine components","volume":"10","author":"Gao","year":"2014","journal-title":"Human Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2017.03.066_b0080","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/CDLI.12.5.586-592.2005","article-title":"Analysis of human serum immunoglobulin G against O-acetyl-positive and O-acetyl-negative serogroup W135 meningococcal capsular polysaccharide","volume":"12","author":"Giardina","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2017.03.066_b0085","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.129.6.1367","article-title":"Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2017.03.066_b0090","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1021\/ac5003933","article-title":"Quantification of each serogroup polysaccharide of Neisseria meningitidis in A\/C\/Y\/W-135-DT conjugate vaccine by high-performance anion-exchange chromatography-pulsed amperometric detection analysis","volume":"86","author":"Gudlavalleti","year":"2014","journal-title":"Anal Chem"},{"key":"10.1016\/j.vaccine.2017.03.066_b0095","first-page":"85","article-title":"Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease","volume":"7","author":"Hedari","year":"2014","journal-title":"Infect Drug Resis"},{"key":"10.1016\/j.vaccine.2017.03.066_b0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0021-9258(18)56740-5","article-title":"The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine, and its analytical application","volume":"180","author":"Hestrin","year":"1949","journal-title":"J Biolog Chem"},{"key":"10.1016\/j.vaccine.2017.03.066_b0105","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0264-410X(00)00261-9","article-title":"Assessment of the stability and immunogenicity of meningococcal oligosaccharide C-CRM197 conjugate vaccines","volume":"19","author":"Ho","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.066_b0110","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1016\/S0264-410X(02)00342-0","article-title":"Physico-chemical and immunological examination of the thermal stability of tetanus toxoid conjugate vaccines","volume":"20","author":"Ho","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.066_b0115","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1080\/21645515.2015.1033592","article-title":"Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old","volume":"11","author":"Hu","year":"2015","journal-title":"Human Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2017.03.066_b0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1478-7954-11-17","article-title":"Global epidemiology of invasive meningococcal disease","volume":"11","author":"Jafri","year":"2013","journal-title":"Popul Health Metrics"},{"key":"10.1016\/j.vaccine.2017.03.066_b0125","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4161\/hv.5.4.6877","article-title":"Transcutaneous delivery of tetanus toxin Hc fragment induces superior tetanus toxin neutralizing antibody response compared to tetanus toxoid","volume":"5","author":"Johnston","year":"2009","journal-title":"Human Vaccines"},{"key":"10.1016\/j.vaccine.2017.03.066_b0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4161\/hv.3.1.3749","article-title":"Long-term thermal stability of group C meningococcal polysaccharide-tetanus toxoid conjugate vaccine","volume":"3","author":"Lee","year":"2007","journal-title":"Human Vaccines"},{"key":"10.1016\/j.vaccine.2017.03.066_b0135","first-page":"259","article-title":"Quantification of free polysaccharide in meningococcal polysaccharide-diphtheria toxoid conjugate vaccines","volume":"103","author":"Lei","year":"2000","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2017.03.066_b0140","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.vaccine.2015.01.046","article-title":"Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines","volume":"33","author":"Lockyer","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.066_b0145","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2017.03.066_b0150","doi-asserted-by":"crossref","first-page":"19077","DOI":"10.1073\/pnas.1314476110","article-title":"Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X","volume":"110","author":"Micoli","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.03.066_b0155","unstructured":"Moran E, Pisal S, Mallya A, Kale S, Alderson M, Haralson S, et al. Immunogenicity of the meningitis vaccine project's pentavalent MenACWYX polysaccharide conjugate vaccine MCV-5. In: International Pathogenic Neisseria Conference (oral presentation); 2016."},{"key":"10.1016\/j.vaccine.2017.03.066_b0160","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0021-9673(01)93142-5","article-title":"High-performance gel permeation chromatography of meningococcal polysaccharides","volume":"483","author":"Newland","year":"1989","journal-title":"J Chromatogr"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2017.03.066_b0165","doi-asserted-by":"crossref","first-page":"B30","DOI":"10.1016\/j.vaccine.2009.05.003","article-title":"Quadrivalent meningococcal conjugate vaccines","volume":"27","author":"Pace","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.066_b0170","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1586\/erv.12.32","article-title":"MenACWY-TT vaccine for active immunization against invasive meningococcal disease","volume":"11","author":"Papaevangelou","year":"2012","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.03.066_b0175","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1080\/14760584.2016.1187068","article-title":"Fighting Neisseria meningitidis: past and current vaccination strategies","volume":"15","author":"Piccini","year":"2016","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.03.066_b0180","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1016\/j.vaccine.2013.04.070","article-title":"Single priming dose of meningococcal group C conjugate vaccine (NeisVac-C\u00ae) in infants","volume":"31","author":"Poellabauer","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.066_b0185","doi-asserted-by":"crossref","unstructured":"Ravenscroft N, Costantino P, Talaga P, Rodriguez R, Egan W. In: Nunnally BK, Turula VE, Sitrin RD, editor. Glycoconjugate vaccines. vaccine analysis: strategies, principles, and control. vol. 8; 2015. p. 301\u201381.","DOI":"10.1007\/978-3-662-45024-6_8"},{"key":"10.1016\/j.vaccine.2017.03.066_b0190","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0264-410X(00)00427-8","article-title":"Development of a new method for the quantitative analysis of the extracellular polysaccharide of Neisseria meningitidis serogroup A by use of high-performance anion-exchange chromatography with pulsed-amperometric detection","volume":"19","author":"Ricci","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.066_b0195","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1016\/j.vaccine.2016.09.003","article-title":"Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine","volume":"34","author":"Robertson","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.066_b0200","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1016\/j.vaccine.2010.07.005","article-title":"Immunogenicity and thermal stability of a combined vaccine against Haemophilus influenzae type b and Neisseria meningitidis serogroup C diseases","volume":"28","author":"Saydam","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.066_b0205","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/CDLI.7.5.764-768.2000","article-title":"Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitidis serogroup C vaccines","volume":"7","author":"Sikkema","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2017.03.066_b0210","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1586\/14760584.3.5.533","article-title":"Control and lot release of meningococcal group C conjugate vaccines","volume":"3","author":"Suker","year":"2004","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.03.066_b0215","first-page":"43","article-title":"Enhanced stability of meningococcal polysaccharide vaccines by using lactose as a menstruum for lyophilization","volume":"55","author":"Tiesjema","year":"1977","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.03.066_b0220","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1016\/j.vaccine.2013.07.078","article-title":"Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines","volume":"31","author":"Tontini","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.066_b0225","doi-asserted-by":"crossref","unstructured":"Varley P. Fluorescence spectroscopy. In: Jones C, Mulloy B, Thomas A, editor. Microscopy, optical spectroscopy and macroscopic techniques. vol. 15; 1994. p. 203\u201318.","DOI":"10.1385\/0-89603-232-9:203"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2017.03.066_b0230","doi-asserted-by":"crossref","first-page":"B10","DOI":"10.1016\/j.vaccine.2011.12.060","article-title":"History of meningococcal vaccines and their serological correlates of protection","volume":"30","author":"Vipond","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.066_b0235","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0165-022X(03)00066-6","article-title":"Simple and rapid technique for monitoring the quality of meningococcal polysaccharides by high performance size-exclusion chromatography","volume":"56","author":"von Hunolstein","year":"2003","journal-title":"J Biochem Biophys Methods"},{"key":"10.1016\/j.vaccine.2017.03.066_b0240","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/CVI.00121-15","article-title":"Needle-free dermal delivery of a diphtheria toxin CRM197 mutant on potassium-doped hydroxyapatite microparticles","volume":"22","author":"Weissmueller","year":"2015","journal-title":"Clin Vaccine Immun CVI"},{"key":"10.1016\/j.vaccine.2017.03.066_b0245","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1586\/erv.13.48","article-title":"Intradermal powder immunization with protein-containing vaccines","volume":"12","author":"Weissmueller","year":"2013","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.03.066_b0250","unstructured":"WHO. Cerebrospinal meningitis control. Report of a WHO study group. World Health Organization technical report series; 1976. p. 1\u201329."},{"key":"10.1016\/j.vaccine.2017.03.066_b0255","unstructured":"WHO. WHO Expanded Program on Immunization. Use of MenAfriVac (meningitis A vaccine) in a controlled temperature chain (CTC) during campaigns: guidance for immunization programme decision makers and managers; 2013. <www.who.int\/vaccines-documents\/>."},{"key":"10.1016\/j.vaccine.2017.03.066_b0260","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.1016\/j.vaccine.2012.07.032","article-title":"Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies","volume":"30","author":"Xie","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.066_b0265","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/IAI.37.1.89-103.1982","article-title":"Hydrolytic stability of pneumococcal group 6 (type 6A and 6B) capsular polysaccharides","volume":"37","author":"Zon","year":"1982","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T11:04:13Z","timestamp":1658919853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17303936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":53,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0264410X17303936"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.066","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM197, DT and TT glycoconjugate vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}